DENVER — August 28, 2014 — Corgenix Medical Corporation (OTC QB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, today announced that it has entered into a definitive merger ...

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC QB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, today announced that it has entered into a definitive merger ...

MAINZ, Germany, April 9, 2019 /PRNewswire/ -- Orgentec Diagnostika, a leading specialty diagnostics company, announced today that its board of directors has appointed Gary Winer to president and chief ...

Corgenix Medical said today it agreed to be acquired by Orgentec Diagnostika for about $16 million, creating a combined company with an extended global distribution network and a broader portfolio of ...

CROISSY-BEAUBOURG, France--(BUSINESS WIRE)--Regulatory News: THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today ...

Water Street Healthcare Partners portfolio company Orgentec Diagnostika GmbH will acquire Corgenix Medical Corp., a developer and diagnostic test kits, in a transaction valued at about $16 million.

Orgentec Diagnostika has completed its acquisition of Broomfield-based Corgenix Medical Corp., according to a filing made Wednesday with the U.S. Securities and Exchange Commission. In the filing, ...

"The combination of Gary's diagnostic and global experience is the ideal match for Orgentec. We're thrilled to gain the benefit of his years of industry expertise and insight as we build and enhance ...

- Over the course of his more than 20-year career, Mr. Winer has held senior leadership positions on an international scale with numerous diagnostic and pharmaceutical businesses, including AbbVie, ...